Smartwatch-Style sensor aims to rehabilitate Stroke-Weakened arms

NCT ID NCT05626894

Recruiting now Symptom relief Sponsor: Spaulding Rehabilitation Hospital Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This Phase 2 trial tests a wrist-worn sensor system called StrokeWear, combined with goal-setting and daily action planning, to encourage stroke survivors to use their weaker arm more during everyday activities. The study enrolls 32 chronic stroke survivors who will either use the system for 6 months or follow a standard home exercise plan. The goal is to see if the device and coaching improve arm movement and real-world use.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: StrokeWear wrist sensor and behavioral intervention
What this could lead to: If successful, this could offer a practical home-based tool to improve arm function and daily use for chronic stroke survivors.
What could go wrong: This is a small early-phase trial with only 32 participants, so results may not apply broadly. The intervention requires consistent patient engagement, which may be challenging.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMIPARESIS; POSTSTROKE/CVA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEMIPARESIS; POSTSTROKE/CVA STROKE STROKE SEQUELAE

Contacts and locations

Locations

Spaulding Rehabilitation Hospital Boston
RECRUITING

Boston, Massachusetts, 02129, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.